Ongoing HIV stigma hampers testing, treatment and prevention. Multilayered impacts necessitate community initiatives and the dismantling of discriminatory laws for effective collaboration, which are essential for achieving HIV elimination goals.
MedinCell Receives Prime ISS ESG Rating as a Recognition of the Embedment of Corporate Social Responsibility Across the Company streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
23.02.2023 - Regulatory News: MedinCell (Paris:MEDCL): “This recognition is a tribute to MedinCell efforts and performance.” said Christophe Douat, CEO of MedinCell. “Strong ESG performance is an increasingly important factor in attracting investors and the . Seite 1
Institutional Shareholder Services (ISS) awarded MedinCell a "Prime" Environmental, Social, and Governance (ESG) rating. Rating places MedinCell among the top 10% in the Pharmaceuticals Biotechnology
/PRNewswire/ The "Long-Acting Injectable Drugs" report has been added to ResearchAndMarkets.com s offering. Chronic conditions require drug administration.